Highlights CNBX Pharmaceuticals Inc.

Equities

CNBX

US13764M2098

Market Closed - OTC Markets Other stock markets 03:21:44 2024-05-06 pm EDT			5-day change	1st Jan Change
0.0102 ^USD	-10.53%		0.00%	-28.17%

Apr. 16	CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	CI
Jan. 12	CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	Apr. 16	CI
CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023	Jan. 12	CI
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended August 31, 2023	Nov. 30	CI
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023	23-07-14	CI
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023	23-04-14	CI
CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2022	23-01-13	CI
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended August 31, 2022	22-11-30	CI
CNBX Pharmaceuticals Inc. acquired unknown stake in TaGeza Biopharmaceuticals Ltd.	22-11-07	CI
CNBX Pharmaceuticals Inc. Announces That the Company Has Filed A New Patent Application Titled " Compositions Comprising Cannabinoids and Methods of Use Thereof in the Treatment of Cancer" Under the Patent Cooperation Treaty	22-10-18	CI
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2022	22-07-14	CI
CNBX Pharmaceuticals Inc. Receives Grant of Patent Notice by the Patent Registry, Intellectual Property Department, the Government of the Hong Kong Special Administrative Region	22-05-05	CI
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2022	22-04-12	CI
CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2021	22-01-13	CI
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended August 31, 2021	21-11-29	CI
CANNABICS PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)	21-11-19	AQ
Cannabics Pharmaceuticals Inc. Files 2 Provisional Patents on Compositions and Methods for Treating Cancer	21-10-18	CI
Cannabics Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter Ended May 31, 2021	21-07-14	CI
Cannabics Pharmaceuticals Releases Interim Results of Second In-Vivo POC Study	21-06-28	CI
Cannabics Pharmaceuticals Inc. to Launch Drug Development Programs for Prostate Cancer and Neurodegenerative & Mental Health Diseases	21-06-17	CI
Cannabics Pharmaceuticals Inc. Launches a Breast Cancer Treatment Research Program	21-06-03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights CNBX Pharmaceuticals Inc.

Equities

CNBX

US13764M2098

Highlights

Filters